Literature DB >> 20141508

The sulfamide motif in the design of enzyme inhibitors.

Jean-Yves Winum1, Andrea Scozzafava, Jean-Louis Montero, Claudiu T Supuran.   

Abstract

The sulfamide moiety, similarly to the structurally related sulfonamide and sulfamate ones, is widely employed in medicinal chemistry for the design of biologically active compounds. Amongst the enzymes for which sulfamide-based inhibitors were designed are the carbonic anhydrases (CAs), and a large number of proteases belonging to the aspartic protease (HIV-1 protease, gamma-secretase), serine protease (elastase, chymase, tryptase and thrombin, among others) and metalloproteinase (carboxypeptidase A [CPA] and matrix metalloproteinase [MMP]) families. Some steroid sulfatase (STS) and protein tyrosine phosphatase inhibitors belonging to the sulfamide class of derivatives have also been reported. In all these compounds, many of which show low nanomolar affinity for the target enzymes for which they have been designed, the free or substituted sulfamide moiety plays an important role in the binding of the inhibitor to the active site cavity. This is achieved either by directly coordinating to the metal ion found in some metalloenzymes (CAs, CPA, STS), usually by means of one of the nitrogen atoms present in the sulfamide motif, or, as in the case of the cyclic sulfamides, acting as HIV protease inhibitors interacting with the catalytically critical aspartic acid residues of the active site by means of an oxygen atom belonging to the HN-SO(2)-NH motif that substitutes a catalytically essential water molecule. In other cases, the sulfamide moiety is important for inducing desired physicochemical properties to the drug-like compounds incorporating it, such as enhanced water solubility, better bioavailability etc., due to the intrinsic properties of this highly polarised moiety when attached to an organic scaffold. This interesting motif is, thus, of great value for the design of pharmacological agents with many applications.

Entities:  

Year:  2006        PMID: 20141508     DOI: 10.1517/13543776.16.1.27

Source DB:  PubMed          Journal:  Expert Opin Ther Pat        ISSN: 1354-3776            Impact factor:   6.674


  15 in total

1.  Complementary regioselectivity in the Cu(I)-catalyzed diamination of conjugated dienes to form cyclic sulfamides.

Authors:  Richard G Cornwall; Baoguo Zhao; Yian Shi
Journal:  Org Lett       Date:  2010-12-30       Impact factor: 6.005

2.  Novel, broad-spectrum anticonvulsants containing a sulfamide group: pharmacological properties of (S)-N-[(6-chloro-2,3-dihydrobenzo[1,4]dioxin-2-yl)methyl]sulfamide (JNJ-26489112).

Authors:  David F McComsey; Virginia L Smith-Swintosky; Michael H Parker; Douglas E Brenneman; Ewa Malatynska; H Steve White; Brian D Klein; Karen S Wilcox; Michael E Milewski; Mark Herb; Michael F A Finley; Yi Liu; Mary Lou Lubin; Ning Qin; Allen B Reitz; Bruce E Maryanoff
Journal:  J Med Chem       Date:  2013-11-11       Impact factor: 7.446

3.  Chemoselective amination of propargylic C(sp³)-H bonds by cobalt(II)-based metalloradical catalysis.

Authors:  Hongjian Lu; Chaoqun Li; Huiling Jiang; Christopher L Lizardi; X Peter Zhang
Journal:  Angew Chem Int Ed Engl       Date:  2014-05-19       Impact factor: 15.336

4.  Synthesis, anti-cancer screening and tyrosyl-DNA phosphodiesterase 1 (Tdp1) inhibition activity of novel piperidinyl sulfamides.

Authors:  Jung Ho Jun; Vineet Kumar; Thomas S Dexheimer; Iwona Wedlich; Marc C Nicklaus; Yves Pommier; Sanjay V Malhotra
Journal:  Eur J Pharm Sci       Date:  2017-10-13       Impact factor: 4.384

5.  Stereoselective radical amination of electron-deficient C(sp3)-H bonds by Co(II)-based metalloradical catalysis: direct synthesis of α-amino acid derivatives via α-C-H amination.

Authors:  Hongjian Lu; Yang Hu; Huiling Jiang; Lukasz Wojtas; X Peter Zhang
Journal:  Org Lett       Date:  2012-09-21       Impact factor: 6.005

6.  Synthetic methodology for the preparation of N-hydroxysulfamides.

Authors:  Krishnaswamy Devanathan; Jennifer A Bell; Patricia C Wilkins; Hollie K Jacobs; Aravamudan S Gopalan
Journal:  Tetrahedron Lett       Date:  2007-11-05       Impact factor: 2.415

7.  Catalytic asymmetric synthesis of cyclic sulfamides from conjugated dienes.

Authors:  Richard G Cornwall; Baoguo Zhao; Yian Shi
Journal:  Org Lett       Date:  2013-01-30       Impact factor: 6.005

8.  Investigation on the Anticancer Activity of Symmetric and Unsymmetric Cyclic Sulfamides.

Authors:  Jaden Jungho Jun; Divya Duscharla; Ramesh Ummanni; Paul R Hanson; Sanjay V Malhotra
Journal:  ACS Med Chem Lett       Date:  2021-01-15       Impact factor: 4.345

9.  Vicinal diamination of alkenes under Rh-catalysis.

Authors:  David E Olson; Justin Y Su; D Allen Roberts; J Du Bois
Journal:  J Am Chem Soc       Date:  2014-09-18       Impact factor: 15.419

10.  Hydrophobic substituents of the phenylmethylsulfamide moiety can be used for the development of new selective carbonic anhydrase inhibitors.

Authors:  Giuseppina De Simone; Ginta Pizika; Simona Maria Monti; Anna Di Fiore; Jekaterina Ivanova; Igor Vozny; Peteris Trapencieris; Raivis Zalubovskis; Claudiu T Supuran; Vincenzo Alterio
Journal:  Biomed Res Int       Date:  2014-09-02       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.